During the corresponding time, Icu Medical Inc saw a revenue deteriorated by -12.4 % year on year, sequentially revenue fell by -2.39 %. While revenue at the Icu Medical Inc's corporate clients
Icu Medical Inc's Comment on Sales, Marketing and Customers
ICU Medical serves customers including acute care hospitals, wholesalers, ambulatory clinics, outpatient clinics, home health care providers, and long-term care facilities. The company’s product portfolio includes ambulatory, syringe, and large volume IV pumps; safety software; IV sets; needlefree IV connectors; peripheral IV catheters; sharps safety products; sterile IV solutions; closed system transfer devices; pharmacy compounding systems; respiratory, anesthesia, patient monitoring, and temperature management products. ICU Medical has expanded through acquisitions of Pfizer Inc.'s Hospira Infusion Systems business, Pursuit Vascular, Inc., and Smiths Medical 2020 Limited. It also formed a joint venture with Otsuka Pharmaceutical Factory America, Inc. for its IV Solutions business, retaining 40% ownership and continuing to sell and distribute products for the joint venture. The company’s market segments include infusion therapy, oncology, vascular access, and tracheostomy products, with applications in hospitals and ambulatory clinics for intravenous infusion therapy and catheter maintenance.
Icu Medical Inc’s Comment on Sales, Marketing and Customers
ICU Medical serves customers including acute care hospitals, wholesalers, ambulatory clinics, outpatient clinics, home health care providers, and long-term care facilities. The company’s product portfolio includes ambulatory, syringe, and large volume IV pumps; safety software; IV sets; needlefree IV connectors; peripheral IV catheters; sharps safety products; sterile IV solutions; closed system transfer devices; pharmacy compounding systems; respiratory, anesthesia, patient monitoring, and temperature management products. ICU Medical has expanded through acquisitions of Pfizer Inc.'s Hospira Infusion Systems business, Pursuit Vascular, Inc., and Smiths Medical 2020 Limited. It also formed a joint venture with Otsuka Pharmaceutical Factory America, Inc. for its IV Solutions business, retaining 40% ownership and continuing to sell and distribute products for the joint venture. The company’s market segments include infusion therapy, oncology, vascular access, and tracheostomy products, with applications in hospitals and ambulatory clinics for intravenous infusion therapy and catheter maintenance.
Sources:
Icu Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Icu Medical Inc’s corporate clients.
For your research, we’ve provided 9 tables on Icu Medical Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
102.88 %